Avoiding Medicare: Lilly, Icos and Limiting Part D Exposure

Lilly's acquisition of Icos is a big bet on the future of private pay medicines. Lilly is paying $2.1 billion for sole rights to Cialis, in part because the company is happy to have a brand that operates outside of the influence of managed care gatekeepers in the US.